{"id":"https://openalex.org/W2109547013","doi":"https://doi.org/10.1097/00004872-200106000-00020","title":"Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial","display_name":"Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial","publication_year":2001,"publication_date":"2001-06-01","ids":{"openalex":"https://openalex.org/W2109547013","doi":"https://doi.org/10.1097/00004872-200106000-00020","mag":"2109547013","pmid":"https://pubmed.ncbi.nlm.nih.gov/11403364"},"language":"en","primary_location":{"id":"doi:10.1097/00004872-200106000-00020","doi":"https://doi.org/10.1097/00004872-200106000-00020","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004872-200106000-00020","pdf_url":null,"source":{"id":"https://openalex.org/S115964404","display_name":"Journal of Hypertension","issn_l":"0263-6352","issn":["0263-6352","1473-5598"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hypertension","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2109547013"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111847356","display_name":"Peter Sever","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Peter S. Sever","raw_affiliation_strings":["Imperial College School of Medicine, London, UK. p.sever@ic.ac.uk","Imperial College School of Medicine, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imperial College School of Medicine, London, UK. p.sever@ic.ac.uk","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"Imperial College School of Medicine, London, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016902658","display_name":"Bj\u00f6rn Dahl\u00f6f","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801112325","display_name":"Sahlgrenska University Hospital","ror":"https://ror.org/04vgqjj36","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I2801112325"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Bj\u00f6rn Dahl\u00f6f","raw_affiliation_strings":["Clinical Trial Unit, Department of Medicine, Sahlgrenska University Hospital, \u00d6stra"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Trial Unit, Department of Medicine, Sahlgrenska University Hospital, \u00d6stra","institution_ids":["https://openalex.org/I2801112325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072011562","display_name":"Neil R Poulter","orcid":"https://orcid.org/0000-0002-6292-997X","observed_orcids":["https://orcid.org/0000-0002-6292-997X"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Neil R. Poulter","raw_affiliation_strings":["Imperial College School of Medicine, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imperial College School of Medicine, London, UK","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005456371","display_name":"Hans Wedel","orcid":"https://orcid.org/0000-0001-7571-0021","observed_orcids":["https://orcid.org/0000-0001-7571-0021"]},"institutions":[{"id":"https://openalex.org/I4210158614","display_name":"Nordic School of Public Health","ror":"https://ror.org/03gfs5c49","country_code":"SE","type":"education","lineage":["https://openalex.org/I4210158614"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Hans Wedel","raw_affiliation_strings":["Nordiska H\u00e4lsov\u00e5rdsh\u00e4gskolan, G\u00f6tenborg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nordiska H\u00e4lsov\u00e5rdsh\u00e4gskolan, G\u00f6tenborg, Sweden","institution_ids":["https://openalex.org/I4210158614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005092835","display_name":"Gareth Beevers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799802789","display_name":"Birmingham City Hospital","ror":"https://ror.org/02smq5q54","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799630439","https://openalex.org/I2799802789"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gareth Beevers","raw_affiliation_strings":["City Hospital, Birmingham"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City Hospital, Birmingham","institution_ids":["https://openalex.org/I2799802789"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074262853","display_name":"Mark J. Caulfield","orcid":"https://orcid.org/0000-0001-9295-3594","observed_orcids":["https://orcid.org/0000-0001-9295-3594"]},"institutions":[{"id":"https://openalex.org/I1307195382","display_name":"St Bartholomew's Hospital","ror":"https://ror.org/00nh9x179","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1307195382","https://openalex.org/I225661044"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mark Caulfield","raw_affiliation_strings":["St Bartholmews Hospital, London"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St Bartholmews Hospital, London","institution_ids":["https://openalex.org/I1307195382"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090621185","display_name":"Rory Collins","orcid":"https://orcid.org/0000-0001-8288-8602","observed_orcids":["https://orcid.org/0000-0001-8288-8602","https://orcid.org/0000-0002-3387-6629"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rory Collins","raw_affiliation_strings":["Radcliffe Infirmary, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radcliffe Infirmary, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087577272","display_name":"Sverre Erik Kjeldsen","orcid":"https://orcid.org/0000-0003-2389-0272","observed_orcids":["https://orcid.org/0000-0003-2389-0272"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Sverre E. Kjeldsen","raw_affiliation_strings":["Ullev\u00e5l Sykehus, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ullev\u00e5l Sykehus, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111429189","display_name":"Gordon T. McInnes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801120601","display_name":"Western Infirmary","ror":"https://ror.org/02e22bh87","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800201399","https://openalex.org/I2801120601"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gordon T. McInnes","raw_affiliation_strings":["Western Infirmary, Glasgow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Western Infirmary, Glasgow, UK","institution_ids":["https://openalex.org/I2801120601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006960710","display_name":"Jesper Mehlsen","orcid":"https://orcid.org/0000-0002-1720-0581","observed_orcids":["https://orcid.org/0000-0002-1720-0581"]},"institutions":[{"id":"https://openalex.org/I2801150652","display_name":"Frederiksberg Hospital","ror":"https://ror.org/00d264c35","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2801150652","https://openalex.org/I2802567020"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Jesper Mehlsen","raw_affiliation_strings":["H. S. Frederiksberg Hospital, Frederiksberg , Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. S. Frederiksberg Hospital, Frederiksberg , Denmark","institution_ids":["https://openalex.org/I2801150652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058664894","display_name":"Markku S. Nieminen","orcid":"https://orcid.org/0000-0002-3802-6738","observed_orcids":["https://orcid.org/0000-0002-3802-6738"]},"institutions":[{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Markku Nieminen","raw_affiliation_strings":["University Central Hospital, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Central Hospital, Helsinki, Finland","institution_ids":["https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001089931","display_name":"Eoin T O'Brien","orcid":"https://orcid.org/0000-0001-5417-7977","observed_orcids":["https://orcid.org/0000-0001-5417-7977"]},"institutions":[{"id":"https://openalex.org/I2801846703","display_name":"Beaumont Hospital","ror":"https://ror.org/043mzjj67","country_code":"IE","type":"healthcare","lineage":["https://openalex.org/I2801846703"]}],"countries":["IE"],"is_corresponding":false,"raw_author_name":"Eoin O'Brien","raw_affiliation_strings":["Beaumont Hospital, Dublin, Ireland and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beaumont Hospital, Dublin, Ireland and","institution_ids":["https://openalex.org/I2801846703"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028660133","display_name":"Jan \u00d6stergren","orcid":"https://orcid.org/0000-0001-5676-3195","observed_orcids":["https://orcid.org/0000-0001-5676-3195"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]},{"id":"https://openalex.org/I4210106957","display_name":"St Mary's Hospital","ror":"https://ror.org/01aysdw42","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I4210106957"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB","SE"],"is_corresponding":false,"raw_author_name":"Jan Ostergren","raw_affiliation_strings":["Karolinska Hospital, Stockholm, Sweden. (The ASCOT Steering Committee, for the ASCOT investigators.)","Sponsorship: The principal sponsor of ASCOT is Pfizer Inc. New York. Funding has also been provided by Parke Davis, Ann Arbor, Michigan. Additional study medication was donated by the Servier Research Group, Paris and Leo Laboratories, Copenhagen","and requests for reprints to Professor P. Sever, Clinical Pharmacology, Imperial College School of Medicine, NHLI Division, St Mary's Hospital London W2 INY, UK. Tel: +44 0207 886 1117; fax: +44 0207 886 6145: email: [email\u00a0protected]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Karolinska Hospital, Stockholm, Sweden. (The ASCOT Steering Committee, for the ASCOT investigators.)","institution_ids":["https://openalex.org/I1335113835"]},{"raw_affiliation_string":"Sponsorship: The principal sponsor of ASCOT is Pfizer Inc. New York. Funding has also been provided by Parke Davis, Ann Arbor, Michigan. Additional study medication was donated by the Servier Research Group, Paris and Leo Laboratories, Copenhagen","institution_ids":[]},{"raw_affiliation_string":"and requests for reprints to Professor P. Sever, Clinical Pharmacology, Imperial College School of Medicine, NHLI Division, St Mary's Hospital London W2 INY, UK. Tel: +44 0207 886 1117; fax: +44 0207 886 6145: email: [email\u00a0protected]","institution_ids":["https://openalex.org/I4210106957","https://openalex.org/I47508984"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":13,"corresponding_author_ids":["https://openalex.org/A5111847356"],"corresponding_institution_ids":["https://openalex.org/I47508984"],"apc_list":null,"apc_paid":null,"fwci":13.8915,"has_fulltext":false,"cited_by_count":268,"citation_normalized_percentile":{"value":0.99192306,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"19","issue":"6","first_page":"1139","last_page":"1147"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12075","display_name":"Sodium Intake and Health","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.828000009059906},{"id":"https://openalex.org/keywords/coronary-heart-disease-prevention","display_name":"coronary heart disease prevention","score":0.8159999847412109},{"id":"https://openalex.org/keywords/primary-prevention","display_name":"primary prevention","score":0.7039999961853027},{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.8619999885559082},{"id":"https://openalex.org/keywords/amlodipine","display_name":"amlodipine","score":0.9340000152587891},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.8889999985694885},{"id":"https://openalex.org/keywords/perindopril","display_name":"perindopril","score":0.9940000176429749},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.9869999885559082},{"id":"https://openalex.org/keywords/atenolol","display_name":"atenolol","score":0.9950000047683716},{"id":"https://openalex.org/keywords/diuretics","display_name":"diuretics","score":0.8420000076293945},{"id":"https://openalex.org/keywords/bendroflumethiazide","display_name":"bendroflumethiazide","score":0.9879999756813049},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.9169999957084656},{"id":"https://openalex.org/keywords/atorvastatin","display_name":"atorvastatin","score":1.0},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.6710000038146973},{"id":"https://openalex.org/keywords/trial-design","display_name":"trial design","score":0.6710000038146973},{"id":"https://openalex.org/keywords/power-analysis","display_name":"power analysis","score":0.546999990940094},{"id":"https://openalex.org/keywords/cardiovascular-risk-factors","display_name":"cardiovascular risk factors","score":0.5580000281333923}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9375811219215393},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.6589059233665466},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6196982860565186},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5849258899688721},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.5672239065170288},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5601152181625366},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.5458240509033203},{"id":"https://openalex.org/C2779646130","wikidata":"https://www.wikidata.org/wiki/Q411347","display_name":"Amlodipine","level":3,"score":0.5450369119644165},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.518393337726593},{"id":"https://openalex.org/C204243189","wikidata":"https://www.wikidata.org/wiki/Q1363085","display_name":"Randomization","level":3,"score":0.5037917494773865},{"id":"https://openalex.org/C2779200603","wikidata":"https://www.wikidata.org/wiki/Q277785","display_name":"Perindopril","level":3,"score":0.49384981393814087},{"id":"https://openalex.org/C2779918671","wikidata":"https://www.wikidata.org/wiki/Q200656","display_name":"Diuretic","level":2,"score":0.46198588609695435},{"id":"https://openalex.org/C2780356492","wikidata":"https://www.wikidata.org/wiki/Q421700","display_name":"Calcium channel blocker","level":3,"score":0.4522190988063812},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4491996169090271},{"id":"https://openalex.org/C57900726","wikidata":"https://www.wikidata.org/wiki/Q492905","display_name":"Diastole","level":3,"score":0.42341285943984985},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002985","descriptor_name":"Clinical Protocols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003327","descriptor_name":"Coronary Disease","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D004232","descriptor_name":"Diuretics","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006113","descriptor_name":"United Kingdom","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012537","descriptor_name":"Scandinavian and Nordic Countries","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1097/00004872-200106000-00020","doi":"https://doi.org/10.1097/00004872-200106000-00020","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004872-200106000-00020","pdf_url":null,"source":{"id":"https://openalex.org/S115964404","display_name":"Journal of Hypertension","issn_l":"0263-6352","issn":["0263-6352","1473-5598"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hypertension","raw_type":"journal-article"},{"id":"pmid:11403364","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11403364","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of hypertension","raw_type":"Clinical Trial"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/2ac6085c-3c8e-4b6f-97a4-d6a62acbb7d8","doi":null,"is_oa":false,"landing_page_url":"https://research.birmingham.ac.uk/en/publications/2ac6085c-3c8e-4b6f-97a4-d6a62acbb7d8","pdf_url":null,"source":{"id":"https://openalex.org/S4306402634","display_name":"University of Birmingham Research Portal (University of Birmingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79619799","host_organization_name":"University of Birmingham","host_organization_lineage":["https://openalex.org/I79619799"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Sever, PS, Dahlof, B, Poulter, NR, Weldel, H, Beevers, D, Caulfields, M, Collins, R, Kjeldsen, S & McInnes, GT 2001, 'Rationale, design, methods and baseline demography of participating of the Anglo Scandinavian Cardiac Outcome Trial', Journal of Hypertension, vol. 19, pp. 1139-1147. https://doi.org/10.1097/00004872-200106000-00020","raw_type":"article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/9355e08b-bf05-419d-98db-9bfc665151fc","doi":null,"is_oa":false,"landing_page_url":"https://researchprofiles.ku.dk/da/publications/9355e08b-bf05-419d-98db-9bfc665151fc","pdf_url":null,"source":{"id":"https://openalex.org/S4306401983","display_name":"Research at the University of Copenhagen (University of Copenhagen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I124055696","host_organization_name":"University of Copenhagen","host_organization_lineage":["https://openalex.org/I124055696"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Sever, P S, Dahl\u00f6f, B, Poulter, N R, Wedel, H, Beevers, G, Caulfield, M, Collins, R, Kjeldsen, S E, McInnes, G T, Mehlsen, J, Nieminen, M, O'Brien, E & Ostergren, J 2001, 'Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators', Journal of Hypertension, vol. 19, no. 6, pp. 1139-47.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:www.julkari.fi:10024/88726","doi":null,"is_oa":false,"landing_page_url":"http://www.julkari.fi/handle/10024/88726","pdf_url":null,"source":{"id":"https://openalex.org/S4306402058","display_name":"STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"A"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W871095","https://openalex.org/W22189248","https://openalex.org/W38523360","https://openalex.org/W438375824","https://openalex.org/W1964503909","https://openalex.org/W1999904792","https://openalex.org/W2013256551","https://openalex.org/W2043383629","https://openalex.org/W2043700823","https://openalex.org/W2092805838","https://openalex.org/W2106073810","https://openalex.org/W2107511879","https://openalex.org/W2114634962","https://openalex.org/W2129750583","https://openalex.org/W2137408480","https://openalex.org/W2138119952","https://openalex.org/W2141659719","https://openalex.org/W2150174446","https://openalex.org/W2155598961","https://openalex.org/W2160887918","https://openalex.org/W2165141146","https://openalex.org/W2166089332","https://openalex.org/W2180702045","https://openalex.org/W2312999996","https://openalex.org/W2322095705","https://openalex.org/W2414167269","https://openalex.org/W3080346889","https://openalex.org/W3198570063"],"related_works":["https://openalex.org/W2047985617","https://openalex.org/W2562329777","https://openalex.org/W2321553650","https://openalex.org/W2005287271","https://openalex.org/W2129991662","https://openalex.org/W4253937721","https://openalex.org/W2041759527","https://openalex.org/W2413851649"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1,41],"test":[2,42],"the":[3,33,233,253,267,273,280,286],"primary":[4,34,45],"hypothesis":[5,46],"that":[6,47],"a":[7,30,43,48,63,79,167,183,258,291],"newer":[8],"antihypertensive":[9],"treatment":[10],"regimen":[11,27,271],"(calcium":[12],"channel":[13,269],"blocker":[14],"+/-":[15,29,146,155],"an":[16,25],"angiotensin":[17],"converting":[18],"enzyme":[19],"inhibitor)":[20],"is":[21],"more":[22,241],"effective":[23],"than":[24],"older":[26],"(beta-blocker":[28],"diuretic)":[31],"in":[32,59,263,296],"prevention":[35],"of":[36,170,186,226,261,279,294],"coronary":[37,213],"heart":[38,214],"disease":[39,215],"(CHD).":[40,216],"second":[44],"statin":[49],"compared":[50],"with":[51,62,78,160,182],"placebo":[52,202],"will":[53],"further":[54,161,193],"protect":[55],"against":[56],"CHD":[57,264,297],"endpoints":[58,265,298],"hypertensive":[60],"subjects":[61],"total":[64,184],"cholesterol":[65,185],"<":[66,171,187],"or":[67,108,113,115,121,123,128,130,150,172,188,201,240],"=":[68,109,116,124,131,173,189],"6.5":[69,190],"mmol/l.":[70],"DESIGN:":[71],"Prospective,":[72],"randomized,":[73,225],"open,":[74],"blinded":[75],"endpoint":[76],"trial":[77],"double-blinded":[80],"2":[81,83],"x":[82],"factorial":[84],"component.":[85],"SETTING:":[86],"Patients":[87,139,181],"were":[88,100,192,223,229],"recruited":[89],"mainly":[90],"from":[91],"general":[92],"practices.":[93],"PATIENTS:":[94],"Men":[95],"and":[96,177,211,221,272],"women":[97,222],"aged":[98],"40-79":[99],"eligible":[101],"if":[102],"their":[103],"blood":[104,168],"pressure":[105,169],"was":[106],">":[107,114,122,129],"160":[110],"mmHg":[111,118,126,133,175,179],"systolic":[112,127,176],"100":[117,153],"diastolic":[119,134],"(untreated)":[120],"140":[125,174],"90":[132,178],"(treated)":[135],"at":[136,285],"randomization.":[137],"INTERVENTIONS:":[138],"received":[140],"either":[141,197],"amlodipine":[142],"(5/":[143],"10":[144,199],"mg)":[145,149,154,158],"perindopril":[147],"(4/8":[148],"atenolol":[151],"(50/":[152],"bendroflumethiazide":[156],"(1.25/2.5":[157],"+K+":[159],"therapy":[162],"as":[163],"required":[164],"to":[165,195,256,289],"reach":[166],"diastolic.":[180],"mmol/l":[191],"randomized":[194,231],"receive":[196],"atorvastatin":[198],"mg":[200],"daily.":[203],"MAIN":[204],"OUTCOME":[205],"MEASURE:":[206],"Non-fatal":[207],"myocardial":[208],"infarction":[209],"(MI)":[210],"fatal":[212],"RESULTS:":[217],"19":[218],"342":[219],"men":[220],"initially":[224],"these":[227],"10297":[228],"also":[230],"into":[232],"lipid-lowering":[234,277],"limb.":[235],"All":[236],"patients":[237],"had":[238],"three":[239],"additional":[242],"cardiovascular":[243],"risk":[244],"factors.":[245],"CONCLUSIONS:":[246],"The":[247,276],"study":[248,281],"has":[249,282],"80%":[250],"power":[251,284],"(at":[252],"5%":[254],"level)":[255],"detect":[257,290],"relative":[259,292],"difference":[260,293],"20%":[262],"between":[266,299],"calcium":[268],"blocker-based":[270],"beta-blocker-based":[274],"regimen.":[275],"limb":[278],"90%":[283],"1%":[287],"level":[288],"30%":[295],"groups.":[300]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}